CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2017. The put-call ratio across all filers is 15.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,350,000 | – | 90,502 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 627,111 | $74,068,000 | 20.20% |
| Athos Capital Ltd | 362,909 | $42,863,000 | 11.81% |
| PSquared Asset Management AG | 205,000 | $24,213,000 | 3.85% |
| York Capital Management Global Advisors, LLC | 302,675 | $35,749,000 | 3.52% |
| HHLR ADVISORS, LTD. | 2,962,076 | $349,851,000 | 2.78% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 534,180 | $63,092,000 | 2.58% |
| Pentwater Capital Management LP | 1,178,000 | $139,134,000 | 1.68% |
| Temasek Holdings (Private) Ltd | 1,240,000 | $146,456,000 | 0.63% |
| AQR Arbitrage LLC | 142,733 | $16,858,000 | 0.59% |
| FORT, L.P. | 9,761 | $1,153,000 | 0.34% |